Infantile Hemangioma: Clinical Trials

17 trials for Infantile Hemangioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 5 unknown, 2 terminated, 1 recruiting. 7 Phase 2, 5 Phase 3, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 5, Recruiting 1, Unknown 1
Phase 35Completed 3, Recruiting 1, Unknown 1
Phase 42Terminated 1, Unknown 1
Phase 11Terminated 1

Follow Infantile Hemangioma: new trials by email Literature Review of Infantile Hemangioma trials Research Report on Infantile Hemangioma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
propranolol - Infantile Hemangioma
Phase 2 / Phase 3RecruitingWest China Hospital322025-01-012026-09-21
Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas
Propranolol three times a day, Propranolol twice a day, Timolol - Infantile Hemangioma
Phase 4TerminatedThe University of Texas Health Science Center, Houston522022-06-232026-03-13
''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"
Propranolol Therapy for Infantile Hemangioma - Infantile Hemangioma
Phase 2UnknownAssiut University1002021-01-012020-12-24
Timolol Maleate Gel for the Treatment of Infantile Hemangioma
Timolol Maleate Gel+Placebo, Timolol Maleate Gel, Placebo - Infantile Hemangioma
Phase 2 / Phase 3CompletedAuson Pharmaceuticals Inc.1682020-10-282024-11-07
Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary Hemangioma
oral propranolol, Oral Captopril, intralesional propranolol injection - Infantile Hemangioma
Phase 4UnknownAin Shams University1002019-10-012020-02-28
Hemangiol, Post Marketing Surveillance Study
Infantile Hemangioma
CompletedUniversity Hospital, Montpellier5002019-07-012020-12-02
Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination
Timolol Maleate 0.5% Oph Soln - Infantile Hemangioma
UnknownXiaoXi Lin1502019-02-162019-02-19
Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)
0.25% Timolol Maleate Gel Forming Solution, 0.5% Timolol Maleate Gel Forming Solution - Infantile Hemangioma
Phase 2CompletedKanecia Obie Zimmerman1052017-05-052024-03-12
Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas
oral propranolol, oral atenolol - Infantile Hemangioma
Phase 3UnknownPost Graduate Institute of Medical Education and Research, Chandigarh602017-03-242018-08-28
A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in China
Infantile Hemangioma, Capillary Hemangioma
UnknownZhujiang Hospital100002015-12-012017-06-02
Nadolol Versus Propranolol in Children With Infantile Hemangiomas
Nadolol, Propranolol - Infantile Hemangioma
Phase 3CompletedThe Hospital for Sick Children742015-09-012020-10-28
Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)
topical 0.5% Timolol maleate, Control (placebo) group - Infantile Hemangioma, Very Low Birth Weight Infants
Phase 1TerminatedAlice K. Gong262012-07-012016-11-15
Optical Tomographic Imaging of Infantile Hemangiomas
Infantile Hemangioma
CompletedColumbia University152012-05-012018-08-06
Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to Placebo
propranolol gel, Placebo - Infantile Hemangioma
Phase 2CompletedPierre Fabre Dermatology822012-01-012014-10-30
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care: - Adenovirus, Anesthesia
CompletedDaniel Benjamin35202011-11-012023-09-06
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy
Propranolol, Placebo - Infantile Hemangioma
Phase 2 / Phase 3CompletedPierre Fabre Dermatology5122010-01-012015-12-10
Nadolol for Proliferating Infantile Hemangiomas
Nadolol - Infantile Hemangioma
Phase 2CompletedThe Hospital for Sick Children202009-11-012021-08-19

Narrower conditions

Hemangioma, Capillary (17)  ·  Hemangioma (6)  ·  Adenoviridae Infections (1)  ·  Anxiety Disorders (1)  ·  Arrhythmias, Cardiac (1)  ·  Autistic Disorder (1)  ·  Bipolar Disorder (1)  ·  Bradycardia (1)  ·  Central Nervous System Infections (1)  ·  Cytomegalovirus Retinitis (1)  ·  Endocarditis (1)  ·  Epilepsy (1)  ·  Headache (1)  ·  Healthcare-Associated Pneumonia (1)  ·  Heart Arrest (1)

Broader conditions

Neoplasms by Histologic Type (17)  ·  Neoplasms, Vascular Tissue (17)  ·  Neoplasms (16)  ·  Hemangioma (11)  ·  Brain Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Hemorrhagic Disorders (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Urogenital Diseases (2)

Interventions

Propranolol (5)  ·  Timolol (4)  ·  Nadolol (2)  ·  Alfentanil (1)  ·  Amikacin (1)  ·  Aminocaproic Acid (1)  ·  Atenolol (1)  ·  Bosentan (1)  ·  Captopril (1)  ·  Cefepime (1)  ·  Cidofovir (1)  ·  Ciprofloxacin (1)  ·  Clozapine (1)  ·  Fosfomycin (1)  ·  Haloperidol (1)

Sponsors

Pierre Fabre Dermatology (2)  ·  The Hospital for Sick Children (2)  ·  Ain Shams University (1)  ·  Alice K. Gong (1)  ·  Assiut University (1)  ·  Auson Pharmaceuticals Inc. (1)  ·  Columbia University (1)  ·  Daniel Benjamin (1)  ·  Kanecia Obie Zimmerman (1)  ·  Post Graduate Institute of Medical Education and Research, Chandigarh (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University Hospital, Montpellier (1)  ·  West China Hospital (1)  ·  XiaoXi Lin (1)  ·  Zhujiang Hospital (1)

Countries

United States (6)  ·  Canada (4)  ·  China (4)  ·  France (3)  ·  Egypt (2)  ·  Poland (2)  ·  Spain (2)  ·  Australia (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  India (1)  ·  Israel (1)  ·  Italy (1)  ·  Lithuania (1)

Top investigators

Alice K Gong, M.D. (1)  ·  Alice K Gong, MD (1)  ·  Chi Hornik, PharmD (1)  ·  Christine Labreze, MD (1)  ·  Elena Pope, MD (1)  ·  Elena Pope, MD, MSc (1)  ·  Kanecia Zimmerman, MD, MHS (1)  ·  Kristin Holland, MD (1)  ·  Maria Garzon, MD (1)  ·  Matthew R Greives, MD (1)  ·  Rana Atta, BSc (1)  ·  Tangde Zhang, Doctor (1)  ·  Xiaoxi Lin, PhD (1)

Results publications

PMID 24614374, PMID 24949994, PMID 25693013, PMID 26039810, PMID 26926644, PMID 27522443, PMID 28137820, PMID 28290120, PMID 28779462, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 30790601, PMID 31317556, PMID 31548185, PMID 31814149, PMID 32324313, PMID 32497307, PMID 33029806, PMID 33118199, PMID 33903114, PMID 34302290, PMID 34747977, PMID 35370711, PMID 35491971, PMID 41247430